Loading
A phase 2 trial of cemiplimab, cisplatin, pemetrexed, bevacizumab and other drugs in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting.
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer is a phase 2, randomised interventional study registered as NCT07001618 by Gustave Roussy, Cancer Campus, Grand Paris, with a registry enrolment figure of 162 participants, started 2025-11-17 and due to reach its primary completion in 2030-09. Interventions recorded: MaaT033 capsule; Cemiplimab; Cisplatin; Carboplatine; Pemetrexed (Alimta); Bevacizumab; Paclitaxel; gemcitabine; Docetaxel; Vinorelbine i.v. 25 mg/m²; Vinorelbine oral. Conditions listed: NSCLC (Advanced Non-small Cell Lung Cancer). Primary outcome: Disease Control Rate (DCR). Lung eligibility wording from the registry: "Histologically confirmed diagnosis of NSCLC (adenocarcinoma versus squamous cell carcinoma versus others)". Sites: France. No results are recorded here; the registry entry is the source.
Shares Regeneron, Cemiplimab, Docetaxel, Anti-angiogenic therapy and the tag lung-deep-dive.
Shares Docetaxel, Pemetrexed, Bevacizumab, Anti-angiogenic therapy and the tag lung-deep-dive.
Shares Docetaxel, Pemetrexed, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Docetaxel, Pemetrexed, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Gemcitabine and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Cisplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Gemcitabine, Cisplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Cisplatin, Platinum agents and the tag lung-deep-dive.